Protection against COVID-19 did not wane in six weeks after receipt of fourth dose; protection against infection waned
COVID-19 Linked to Increased Risk for DVT, PE, Bleeding
Rate ratios were highest for critical COVID-19, and during first versus second and third pandemic waves in Sweden
Physician’s Briefing Weekly Coronavirus Roundup
Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of April 4 to 8, 2022. This …
Vaccination Mandate for Federal Workers Reinstated by Appeals Court
Mandate was introduced in September but enforcement was halted in January by a preliminary injunction issued by a federal judge in Texas
Tiger’s Augusta Return Ignites Healthy Optimism
One of America’s classic sporting events begins competition on April 7, 2022, hopefully without COVID-19 clouds.
Since 1934, the Masters' Tournament at the Augusta National golf course has been home to some of golf's greatest moments.
With Tiger Woods returning to the hilly course once again, expectations are sky-high for another thrilling back-nine pairing late on Sunday afternoon.
Furthermore, updated guidance indicates COVID-19 concerns have faded away.
Hundreds of Overseas Flights Canceled After Mask Rules Dropped
Recent increase in canceled flights is the result of ‘higher than usual staff sickness levels’ due to recent surge in COVID-19
FDA Advisers Weigh COVID-19 Booster Shots for Fall
Vaccine experts still guessing at what the ever-changing pandemic will bring
Europe Delays 4th mRNA Vaccinations
The European Centre for Disease Prevention and Control (ECDC) and European Medicine Agency (EMA) COVID-19 task force today announced they have concluded that it is too early to consider using the fourth dose of mRNA COVID-19 vaccines in the general population.
However, both agencies agreed that a 4th dose (or second booster) of Comirnaty and Spikevax can be given to adults 80 years of age and above.
Most COVID-19 Patients Benefit at Long-Term Acute Care Hospitals
Patients treated for COVID-19 discharged with greater improvements in ambulation distance, assistance needs versus reference patients